UNSPSC 51451609: Etibendazole

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51451609

Definition

This classification denotes an antihelminthic agent with the molecular formula C18H16FN3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1XU086MM3H, chemically known as r 34,803 but generally known as etibendazole, which bears US NIH Compound Identifier 71745. European Medicines Agency schedules Etibendazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07295MIG.

Read the full definition

The term ETIBENDAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). ETIBENDAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule etibendazole under HS 29349990 and SITC 51579. As of Q4 2014, ETIBENDAZOLE remains the US FDA Preferred Term for this commodity. Etibendazole bears US NLM identifiers UMLS ID C1880578 and NCI Concept Code C65571. SMILES: FC1CCC(C2(OCCO2)C2CC3[NH]C(NC3CC2)NC(=O)OC)CC1.

About UNSPSC 51451609

UNSPSC 51451609 Etibendazole, a Commodity code, shows no relevant recent state and local procurement activity. The code nominally identifies a specific anthelmintic pharmaceutical, but recent opportunities tagged under this code concern naloxone distribution, direct-to-manufacturer prescription programs, fire department medical supplies, and multi-source generic pharmaceuticals—none of which involve etibendazole procurement. The mismatch between the code's narrow scope and the breadth of unrelated health-services and pharmaceutical-supply opportunities suggests either systematic miscoding in state and local procurement systems or a code that sees little to no active market demand among state, county, municipal, and transit authorities.

The four recent opportunities on file span Seminole County, Florida (naloxone and drug deactivation systems through IFB), the Texas Health and Human Services Commission (exploratory RFI on direct-to-manufacturer prescription programs), the City of Tampa (medical and first aid supplies for fire rescue through IFB, estimated at $700,000), and the Minnesota Multistate Cooperative Purchasing Alliance (generic multi-source pharmaceuticals and OTC products through RFP, effective July 1, 2026). None of these solicitations reference etibendazole or helminth treatments. Firms evaluating this code should verify whether recent state and local RFPs or ITBs specifically name etibendazole before committing development resources, as current market signals do not support active procurement under this Commodity code.

Quick answers

What is UNSPSC 51451609?

UNSPSC 51451609 is Etibendazole, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51451609?

UNSPSC 51451609 maps to 1 NIGP code, 26908 Anti-Infective Agents.

On GovTribe

See everything under UNSPSC 51451609

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code